Your browser doesn't support javascript.
loading
ASO Visual Abstract: Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Fu, Qihan; Chen, Yiwen; Huang, Dabing; Guo, Chengxiang; Zhang, Xiaochen; Xiao, Wenbo; Xue, Xing; Zhang, Qi; Li, Xiang; Gao, Shunliang; Que, Risheng; Shen, Yan; Wu, Jian; Zhang, Min; Bai, Xueli; Liang, Tingbo.
  • Fu Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen Y; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Huang D; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Guo C; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang X; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Xiao W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xue X; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Zhang Q; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Li X; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Gao S; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Que R; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shen Y; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu J; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang M; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Bai X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liang T; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
Ann Surg Oncol ; 30(8): 5081-5082, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37225831
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article